(CIDRAP News) The European Centre for Disease Prevention and Control (ECDC) today said flu transmission is increasing across the European Union (EU), led by a spike in the United Kingdom, and warned people in recommended groups to get vaccinated as soon as possible.
(CIDRAP News) While donor countries and organizations have responded well to the need for pandemic flu vaccine for developing countries, the level of giving for other pandemic response efforts in needy countries so far has fallen short, the World Health Organization (WHO) said in a recent report.
(CIDRAP News) – An independent review of the United Kingdom's response to the H1N1 pandemic gave the government good marks for the way it handled the outbreak, but said the experience yielded useful lessons for the next such health emergency, such as including break clauses in all future vaccine contracts.
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.
(CIDRAP News) After delaying action for weeks as the novel H1N1 influenza virus took hold in far-flung parts of the globe, the World Health Organization (WHO) today declared a full-fledged pandemic, formally recognizing that the virus is becoming a global contagion.
(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.